Abstract

HTA34 Quo Vadis Benefit Assessment for Orphan Drugs in Germany: The End of the Exception?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
PRO94 Outcomes of Benefit Reassessments of Orphan Drugs in Germany after Exceedance of the 50-Million-EURO Revenue Threshold
L Kleinesudeik ... L Frick
Value in Health | VOL. 23
L Kleinesudeik, et. al.L Kleinesudeik ... L Frick
01 Dec 2020
PCN176 - Amnog Benefit Assessment for Oncologic and Orphan Drugs in Germany – Implications for Price Discounts
U Theidel ... T Mittendorf
Value in Health | VOL. 17
U Theidel, et. al.U Theidel ... T Mittendorf
26 Oct 2014
PHP156 Amnog – Summary of Outcomes of Early Benefit Assessment and Reimbursement Negotiation for New Drugs in Germany
W Kotowa ... D Freyer
Value in Health | VOL. 15
W Kotowa, et. al.W Kotowa ... D Freyer
01 Nov 2012
Re: “Early benefit assessment of new drugs in Germany – Results from 2011 to 2012” [Health Policy 116 (2–3) (2014) 147–153
Charalabos-Markos Dintsios ... Tina Orben
Health policy | VOL. 118
Charalabos-Markos Dintsios, et. al.Charalabos-Markos Dintsios ... Tina Orben
22 Oct 2014
View more papers

More From: Value in Health

Paper Title
Journal
Date
Author
Erratum to “Psychometric Evaluation of the Patient’s Knee Implant Performance Questionnaire”
Theresa Coles ... Margaret Mordin
Value in Health | VOL. -
Theresa Coles, et. al.Theresa Coles ... Margaret Mordin
18 May 2024
Consolidated Health Economic Evaluation Reporting Standards for Interventions that use Artificial Intelligence (CHEERS-AI)
Jamie Elvidge ... Dalia Dawoud
Value in Health | VOL. -
Jamie Elvidge, et. al.Jamie Elvidge ... Dalia Dawoud
01 May 2024
Documenting the Full Value of Vaccination: A Systematic Review of Value Frameworks
Abigail G Riley ... Amanda L Eiden
Value in Health | VOL. -
Abigail G Riley, et. al.Abigail G Riley ... Amanda L Eiden
01 May 2024
Further evidence of feasibility, validity and reliability of Quality of Life-Aged Care Consumers: evidence from home-based care settings
Claire Hutchinson ... Jyoti Khadka
Value in Health | VOL. -
Claire Hutchinson, et. al.Claire Hutchinson ... Jyoti Khadka
01 May 2024
View more papers